1-5 of 5
Kena C. Miller, MSN, NP
Close
Sort by
Journal Articles

Renal Dysfunction Does Not Affect Clinical Response in Multiple Myeloma (MM) Patients Treated with Bortezomib-Based Regimens.

Sikander Ailawadhi, MD, Terry L. Mashtare, PhD, Marie V. Coignet, Dawn M. Depaolo, Kena C. Miller, MSN NP, Gregory Wilding, PhD, Asher Alban Chanan-Khan, MD
Journal: Blood
Blood (2007) 110 (11): 1477.
https://doi.org/10.1182/blood.V110.11.1477.1477
Published: 2007
Journal Articles

Determining the Extent of Disease with Magnetic Resonance Imaging of the Bone Marrow (BM-MRI) in Patients with Multiple Myeloma (MM).

Sikander Ailawadhi, MD, Lyudmyla Derby, MD, Terry L. Mashtare, PhD, Kena C. Miller, MSN NP, Gregory Wilding, PhD, Swaminathan Padmanabhan, MD, Ronald Gottlieb, MD MPH, Ronald A. Alberico, MD, Donald L. Klippenstein, MD, Ahmed N. Abdelhalim, MD, Asher A. Chanan-Khan, MD
Journal: Blood
Blood (2007) 110 (11): 1483.
https://doi.org/10.1182/blood.V110.11.1483.1483
Published: 2007
Journal Articles

bcl-2 Translocation [t(14;18) (q32;q21)] Does Not Correlate with Poor Clinical Outcome in Multiple Myeloma Patients Treated with Bortezomib.

Sikander Ailawadhi, MD, Terry L. Mashtare, PhD, Marie V. Coignet, Dawn M. DePaolo, Kena C. Miller, MSN, NP, Swaminathan Padmanabhan, MD, Gregory Wilding, PhD, Petr Starostik, MD, Asher A. Chanan-Khan, MD
Journal: Blood
Blood (2007) 110 (11): 1498.
https://doi.org/10.1182/blood.V110.11.1498.1498
Published: 2007
Journal Articles

Differences in BCL-2 Protein and t(14;18) in Patients with Primary Rituximab/Chemotherapy Refractory Diffuse Large B-Cell Lymphoma (DLBCL).

Sikander Ailawadhi, MD, Francisco J. Hernandez-Ilizaliturri, MD, Loretta Miner, NP, Zale P. Bernstein, MD, Asher Chanan-Khan, MD, Kena C. Miller, MSN NP, Alice Mohr, FNP, Petr Starostik, MD, Myron S. Czuczman, MD, Swaminathan Padmanabhan, MD
Journal: Blood
Blood (2007) 110 (11): 4433.
https://doi.org/10.1182/blood.V110.11.4433.4433
Published: 2007
Journal Articles

Improved Sensitivity of Bone Marrow Magnetic Resonance Imaging (BM-MRI) in Quantifying the Extent of Bone Marrow Involvement in Patients with Multiple Myeloma (MM).

Sikander Ailawadhi, MD, Lyudmyla Derby, MD, Kena C. Miller, MSN NP, Terry L. Mashtare, PhD, Gregory Wilding, PhD, Swaminathan Padmanabhan, MD, Ronald Gottlieb, MD MPH, Ronald A. Alberico, MD, Donald L. Klippenstein, MD, Ahmed N. Abdelhalim, MD, Asher A. Chanan-Khan, MD
Journal: Blood
Blood (2007) 110 (11): 4776.
https://doi.org/10.1182/blood.V110.11.4776.4776
Published: 2007